AARP highlights three major shifts in Medicare Part D for 2026 that will directly impact seniors’ wallets. Foremost is the implementation of lower negotiated prices for 10 high-cost drugs—including Eliquis, Jardiance, and Entresto—which are expected to save enrollees an estimated $1.5 billion collectively.
Additionally, the Part D annual out-of-pocket spending cap has been adjusted to $2,100 for 2026 (up slightly from the initial $2,000 cap introduced in 2025). This indexing reflects standard programmatic adjustments but continues to protect seniors from catastrophic pharmacy bills.
Finally, the maximum Part D deductible has increased to $615 for the year. Beneficiaries are encouraged to use the Medicare Prescription Payment Plan to smooth out these costs over 12 months rather than paying large sums early in the year.